Followers

0
0
0
0
.
3
3
4
4
-0.80 (-1.83%)

As on 10 Oct, 2025 | 16:01

Open Trading A/c
Day Range
41.61
43.80
LH
52 Week Range
31.59
62.56
LH
Volume
* i
Bid / Ask
17,273.00
0.00 / 0.00

Bacil Pharma Announcements

Scrutinizer Report of Shareholders Meeting of the company held on 29th September 2025

30 Sep, 2025 | 03:52pm • Source: BSE

Proceeding of 38th Annual General Meeting of the Company held on September 29, 2025

29 Sep, 2025 | 01:49pm • Source: BSE

Book Closure for the Purpose of Annual General Meeting

05 Sep, 2025 | 02:55pm • Source: BSE

38th Annual Report of the Company

05 Sep, 2025 | 02:51pm • Source: BSE

Notice of 38th Annual General Meeting of the Company

05 Sep, 2025 | 02:45pm • Source: BSE

Outcome of Board Meeting held on 05th September, 2025

05 Sep, 2025 | 02:40pm • Source: BSE

Intimation of Receipt of Request for Reclassifiaction of the Promoter in accordance with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations...

04 Sep, 2025 | 09:01pm • Source: BSE

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2025 ,inter alia, to consider and...

02 Sep, 2025 | 02:09pm • Source: BSE

Revised outcome of Board Meeting held on 25th August 2025. The earlier revised outcome uploaded has incorrect w.e.f date of appointment of statutory auditor. The...

27 Aug, 2025 | 03:02pm • Source: BSE

Approval for Appointment of M/s Sarang Shivajirao Chavan & Associates as the Statutory Auditor of the Company.

27 Aug, 2025 | 02:52pm • Source: BSE

Revised outcome of Board Meeting on 25th August 2025

27 Aug, 2025 | 02:44pm • Source: BSE

Announcement under Regulation 30 (LODR) - Appointment of Statutory Auditor M/s Sarang Shivajirao Chavan & Associates

25 Aug, 2025 | 06:58pm • Source: BSE

Outcome of Board meeting for Appointment Statutory Auditor and Independent Director .

25 Aug, 2025 | 06:51pm • Source: BSE

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 ,inter alia, to consider and...

19 Aug, 2025 | 02:20pm • Source: BSE

Approval of unaudited financial results for the quarter ended 30th June 2025

12 Aug, 2025 | 07:08pm • Source: BSE

Approval of unaudited financial results for the quarter ended 30/06/2025

12 Aug, 2025 | 07:03pm • Source: BSE

Resignation of Mr. Prakash B. Shah with Disclosure as per BSE query

06 Aug, 2025 | 04:48pm • Source: BSE

Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and...

05 Aug, 2025 | 12:31pm • Source: BSE

Compliance-Certificate under Reg.74(5) of SEBI (DP) Regulation,2018

18 Jul, 2025 | 07:50pm • Source: BSE

Appointment of Ms. Chaitali Kalpataru Shah as a Executive Director and CFO of the Company

16 Jul, 2025 | 05:23pm • Source: BSE